Arvinas (ARVN) FCF Margin Growth (1y) (2018 - 2026)
Powered by 
Analysis
Arvinas (ARVN) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 26,102.00 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 869.00 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 769.00 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 811.00 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 19,111.00 |
| 10 | Arvinas | 605.88 Mn | 37.98 Mn | - | 41,183.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41,183.00 |
| Mar 31, 2026 | -40,462.00 |
| Dec 31, 2025 | -17,954.00 |
| Sep 30, 2025 | -1,561.00 |
| Jun 30, 2025 | -49,609.00 |
| Mar 31, 2025 | 33,847.00 |
| Dec 31, 2024 | -33,561.00 |
| Sep 30, 2024 | 12,258.00 |
| Jun 30, 2024 | 22,869.00 |
| Mar 31, 2024 | -10,177.00 |
| Dec 31, 2023 | 38,431.00 |
| Sep 30, 2023 | -4,104.00 |
| Jun 30, 2023 | 7,283.00 |
| Mar 31, 2023 | -6,060.00 |
| Dec 31, 2022 | -7,802.00 |
| Sep 30, 2022 | -752,121.00 |
| Jun 30, 2022 | 63,422.00 |
| Mar 31, 2022 | 50,388.00 |
| Dec 31, 2021 | 37,395.00 |
| Sep 30, 2021 | 762,715.00 |